Almonty Industries witnessed a significant 9.4% decline in its share price, closing at CAD $9.03, as disappointing quarterly operational results overshadowed positive corporate developments. The Canadian tungsten producer reported a 28% revenue increase to CAD $8.7 million but failed to meet market expectations.
The company posted an operating loss of CAD $2.2 million, substantially below analyst projections. In a surprising twist, Almonty recorded a net profit of CAD $33.2 million, primarily driven by financial instrument revaluations that offset operational challenges.
Strategic Acquisition Positions Company for US Defense Contracts
Beyond the quarterly figures, Almonty executed a strategic masterstroke with its recent acquisition of the Gentung-Browns Lake tungsten project in Montana for $10 million. This purchase could establish the company as a primary tungsten supplier to the United States defense sector.
CEO Lewis Black confirmed that production at the Montana site could commence as early as the second half of 2026. This timeline aligns perfectly with the US Department of Defense’s planned 2027 prohibition on tungsten sourcing from China, Russia, and North Korea.
Key advantages of the Montana project include:
* An existing 15-year offtake agreement with a US defense contractor
* Contractual coverage for over 90% of initial production capacity
* Utilization of processed equipment from Spanish operations
* Established water rights and infrastructure accelerating development
Should investors sell immediately? Or is it worth buying Almonty?
Global Expansion Strategy Advances Simultaneously
While pursuing its US offensive, Almonty continues to advance projects across Europe and Asia. At its flagship Panasqueira operation in Portugal, the company launched an extensive drilling program targeting Level 4 – a new production tier expected to extend mine life and boost annual output.
In South Korea, drilling activities at the Sangdong project – one of the largest tungsten deposits outside China – are focusing on the molybdenum component. This strategic move addresses global shortages of this critical metal directly.
Market analysts remain cautiously optimistic about Almonty’s prospects. DA Davidson maintains its “Buy” recommendation with a US $11.00 price target, indicating confidence in the company’s long-term strategy despite current operational headwinds.
Critical Months Ahead for Execution
The coming months will prove decisive for Almonty’s trajectory. Regulatory approvals in Montana and drilling results from Portugal will demonstrate whether the company can translate strategic positioning into operational success. If successfully executed, Almonty stands to benefit disproportionately from ongoing trade conflicts and supply chain restructuring.
Nevertheless, significant challenges persist. Concurrent development of multiple projects, substantial capital requirements, and operational inefficiencies continue to pressure the company’s financial performance. Investors now face the crucial decision of whether the recent price decline represents a buying opportunity or signals further downward momentum.
Ad
Almonty Stock: Buy or Sell?! New Almonty Analysis from November 5 delivers the answer:
The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 5.
Almonty: Buy or sell? Read more here...









